Full metadata record
DC FieldValueLanguage
dc.contributor.authorDürr, Oliver-
dc.contributor.authorFranzini, Anca-
dc.contributor.authorBrutsche, Martin-
dc.contributor.authorBaty, Florent-
dc.date.accessioned2018-12-17T08:19:05Z-
dc.date.available2018-12-17T08:19:05Z-
dc.date.issued2014-
dc.identifier.issn0904-1850de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/13893-
dc.descriptionAbstractde_CH
dc.language.isoende_CH
dc.publisherEuropean Respiratory Societyde_CH
dc.relation.ispartofThe European Respiratory Journalde_CH
dc.rightsLicence according to publishing contractde_CH
dc.subject.ddc572: Biochemiede_CH
dc.subject.ddc616: Innere Medizin und Krankheitende_CH
dc.titleTumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC)de_CH
dc.typeKonferenz: Sonstigesde_CH
dcterms.typeTextde_CH
zhaw.departementSchool of Engineeringde_CH
zhaw.organisationalunitInstitut für Datenanalyse und Prozessdesign (IDP)de_CH
zhaw.conference.details22nd Annual Congress of the European Respiratory Society, Munich, Germany, 6-10 September 2014de_CH
zhaw.funding.euNode_CH
zhaw.issueSuppl 58de_CH
zhaw.originated.zhawYesde_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume44de_CH
zhaw.publication.reviewPeer review (Abstract)de_CH
Appears in collections:Publikationen School of Engineering

Files in This Item:
There are no files associated with this item.
Show simple item record
Dürr, O., Franzini, A., Brutsche, M., & Baty, F. (2014). Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC) [Conference presentation]. The European Respiratory Journal, 44(Suppl 58).
Dürr, O. et al. (2014) ‘Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC)’, in The European Respiratory Journal. European Respiratory Society.
O. Dürr, A. Franzini, M. Brutsche, and F. Baty, “Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC),” in The European Respiratory Journal, 2014, vol. 44, no. Suppl 58.
DÜRR, Oliver, Anca FRANZINI, Martin BRUTSCHE und Florent BATY, 2014. Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC). In: The European Respiratory Journal. Conference presentation. European Respiratory Society. 2014
Dürr, Oliver, Anca Franzini, Martin Brutsche, and Florent Baty. 2014. “Tumor-Associated Stromal Gene Expression Signatures Predict Therapeutic Response to Erlotinib/Bevacizumab in Non-Small Cell Lung Cancer (NSCLC).” Conference presentation. In The European Respiratory Journal. Vol. 44. European Respiratory Society.
Dürr, Oliver, et al. “Tumor-Associated Stromal Gene Expression Signatures Predict Therapeutic Response to Erlotinib/Bevacizumab in Non-Small Cell Lung Cancer (NSCLC).” The European Respiratory Journal, vol. 44, no. Suppl 58, European Respiratory Society, 2014.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.